Healthcare · Drug Manufacturers General · NYSE
| Market cap | $317.57B |
|---|---|
| Trailing P/E | 40.1 |
| FCF yield | 3.8% |
| Revenue growth (YoY) | +1.3% |
| EPS growth (YoY) | +17.4% |
| FCF/share growth (YoY) | -30.8% |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
Merck & Co., Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Jan 9, 2026 |
| Julie Johnson | House | Sell | $1,001 - $15,000 | Jan 5, 2026 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Sep 8, 2025 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Aug 13, 2025 |
| Lisa McClain | House | Buy | $1,001 - $15,000 | Aug 13, 2025 |
| Sheri Biggs | House | Sell | $15,001 - $50,000 | Aug 11, 2025 |
| Ritchie John Torres | House | Buy | $1,001 - $15,000 | Aug 1, 2025 |
| Julie Johnson | House | Buy | $1,001 - $15,000 | Jul 9, 2025 |
| Scott Scott Franklin | House | Sell | $1,001 - $15,000 | Jun 17, 2025 |
| Gilbert Cisneros | House | Sell | $1,001 - $15,000 | Jun 4, 2025 |
| Scott Scott Franklin | House | Buy | $1,001 - $15,000 | May 19, 2025 |
| Rob Bresnahan | House | Sell | $15,001 - $50,000 | May 15, 2025 |